Gastro-oesophageal reflux disease, often abbreviated as GERD, is characterised by symptoms (heartburn, acid regurgitation, irritative cough, dysphonia) that may be accompanied by erosive inflammatory lesions of the oesophageal mucosa. GERD is usually aggravated by supine position and symptoms may worsen at night. ESOXX ONE is an original and innovative combination of hyaluronic acid and chondroitin sulphate, capable of exerting a protective mechanism on the oesophageal mucosa. The presence in the formulation of ESOXX ONE of a component with a high bioadhesive capacity (poloxamer 407), favours the permanence of hyaluronic acid and chondroitin sulphate in the oesophageal mucosa.nic acid and chondroitin sulphate on the surface of the oesophageal wall, contributing to the protective effect against the action of hydrochloric acid produced by the stomach. Chondroitin sulphate also has an action that favours the repair process of the oesophageal mucosa.
